SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-24-011305
Filing Date
2024-01-19
Accepted
2024-01-19 16:44:28
Documents
4
Period of Report
2024-01-19

Document Format Files

Seq Description Document Type Size
1 PRE 14A d575366dpre14a.htm PRE 14A 2395746
3 GRAPHIC g575366g17d02.jpg GRAPHIC 75548
4 GRAPHIC g575366g23z17.jpg GRAPHIC 32308
5 GRAPHIC g575366g58g58.jpg GRAPHIC 88106
  Complete submission text file 0001193125-24-011305.txt   2657858
Mailing Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451
Business Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38130 | Film No.: 24546168
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)